Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Revenue 2010-2025 | AMGN

Amgen annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Amgen revenue for the quarter ending March 31, 2025 was $8.149B, a 9.43% increase year-over-year.
  • Amgen revenue for the twelve months ending March 31, 2025 was $34.126B, a 15.56% increase year-over-year.
  • Amgen annual revenue for 2024 was $33.424B, a 18.57% increase from 2023.
  • Amgen annual revenue for 2023 was $28.19B, a 7.09% increase from 2022.
  • Amgen annual revenue for 2022 was $26.323B, a 1.32% increase from 2021.
  
Amgen Annual Revenue
(Millions of US $)
2024 $33,424
2023 $28,190
2022 $26,323
2021 $25,979
2020 $25,424
2019 $23,362
2018 $23,747
2017 $22,849
2016 $22,991
2015 $21,662
2014 $20,063
2013 $18,676
2012 $17,265
2011 $15,582
2010 $15,053
2009 $14,642
Amgen Quarterly Revenue
(Millions of US $)
2025-03-31 $8,149
2024-12-31 $9,086
2024-09-30 $8,503
2024-06-30 $8,388
2024-03-31 $7,447
2023-12-31 $8,196
2023-09-30 $6,903
2023-06-30 $6,986
2023-03-31 $6,105
2022-12-31 $6,839
2022-09-30 $6,652
2022-06-30 $6,594
2022-03-31 $6,238
2021-12-31 $6,846
2021-09-30 $6,706
2021-06-30 $6,526
2021-03-31 $5,901
2020-12-31 $6,634
2020-09-30 $6,423
2020-06-30 $6,206
2020-03-31 $6,161
2019-12-31 $6,197
2019-09-30 $5,737
2019-06-30 $5,871
2019-03-31 $5,557
2018-12-31 $6,230
2018-09-30 $5,904
2018-06-30 $6,059
2018-03-31 $5,554
2017-12-31 $5,802
2017-09-30 $5,773
2017-06-30 $5,810
2017-03-31 $5,464
2016-12-31 $5,965
2016-09-30 $5,811
2016-06-30 $5,688
2016-03-31 $5,527
2015-12-31 $5,536
2015-09-30 $5,723
2015-06-30 $5,370
2015-03-31 $5,033
2014-12-31 $5,331
2014-09-30 $5,031
2014-06-30 $5,180
2014-03-31 $4,521
2013-12-31 $5,011
2013-09-30 $4,748
2013-06-30 $4,679
2013-03-31 $4,238
2012-12-31 $4,421
2012-09-30 $4,319
2012-06-30 $4,477
2012-03-31 $4,048
2011-12-31 $3,973
2011-09-30 $3,944
2011-06-30 $3,959
2011-03-31 $3,706
2010-12-31 $3,841
2010-09-30 $3,816
2010-06-30 $3,804
2010-03-31 $3,592
2009-12-31 $3,809
2009-09-30 $3,812
2009-06-30 $3,713
2009-03-31 $3,308
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $146.073B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $218.361B 16.30
Gilead Sciences (GILD) United States $133.561B 13.87
Vertex Pharmaceuticals (VRTX) United States $111.963B 0.00
Bristol Myers Squibb (BMY) United States $95.344B 6.38
GSK (GSK) United Kingdom $79.765B 9.48
CSL (CSLLY) Australia $77.232B 0.00
Regeneron Pharmaceuticals (REGN) United States $63.520B 15.42
Alnylam Pharmaceuticals (ALNY) United States $37.807B 0.00
Argenex SE (ARGX) Netherlands $35.879B 97.93
BeiGene (ONC) Cayman Islands $23.913B 0.00
BioNTech SE (BNTX) Germany $23.722B 0.00
Royalty Pharma (RPRX) United States $18.706B 7.71
Biogen (BIIB) United States $18.435B 7.95
Genmab (GNMSF) Denmark $13.767B 14.08
Genmab (GMAB) Denmark $13.343B 14.97
Illumina (ILMN) United States $12.723B 24.14
Incyte (INCY) United States $12.436B 94.48
Insmed (INSM) United States $12.300B 0.00
Exelixis (EXEL) United States $11.560B 19.62
BioMarin Pharmaceutical (BMRN) United States $11.037B 17.93
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Exact Sciences (EXAS) United States $10.743B 0.00
Moderna (MRNA) United States $10.156B 0.00
Ascendis Pharma (ASND) Denmark $9.877B 0.00
QIAGEN (QGEN) Netherlands $9.347B 18.19
Roivant Sciences (ROIV) United Kingdom $7.756B 0.00
Revolution Medicines (RVMD) United States $7.408B 0.00
Bio-Techne Corp (TECH) United States $7.334B 27.36
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.287B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.720B 12.86
Jazz Pharmaceuticals (JAZZ) Ireland $6.661B 6.42
Repligen (RGEN) United States $6.638B 74.31
Blueprint Medicines (BPMC) United States $6.555B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.390B 0.00
Telix Pharmaceuticals (TLX) Australia $5.610B 0.00
TG Therapeutics (TGTX) United States $5.488B 144.04
Legend Biotech (LEGN) United States $5.313B 0.00
Nuvalent (NUVL) United States $5.262B 0.00
Axsome Therapeutics (AXSM) United States $5.173B 0.00
ADMA Biologics Inc (ADMA) United States $4.875B 36.46
Alkermes (ALKS) Ireland $4.840B 12.99
Guardant Health (GH) United States $4.708B 0.00
Zealand Pharma (ZLDPF) Denmark $4.429B 0.00
Vaxcyte (PCVX) United States $4.198B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.967B 0.00
Merus (MRUS) Netherlands $3.816B 0.00
Sarepta Therapeutics (SRPT) United States $3.725B 0.00
Akero Therapeutics (AKRO) United States $3.696B 0.00
Avidity Biosciences (RNA) United States $3.686B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.679B 32.32
Cytokinetics (CYTK) United States $3.647B 0.00
PTC Therapeutics (PTCT) United States $3.640B 6.34
Krystal Biotech (KRYS) United States $3.614B 27.85
Arcellx (ACLX) United States $3.522B 0.00
SpringWorks Therapeutics (SWTX) United States $3.502B 0.00
Zai Lab (ZLAB) China $3.455B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.371B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.183B 0.00
Alvotech (ALVO) Luxembourg $3.099B 17.72
Viking Therapeutics (VKTX) United States $3.030B 0.00
Metsera (MTSR) United States $2.868B 0.00
Scholar Rock Holding (SRRK) United States $2.848B 0.00
Protagonist Therapeutics (PTGX) United States $2.830B 60.88
MoonLake Immunotherapeutics (MLTX) Switzerland $2.492B 0.00
Immunovant (IMVT) United States $2.456B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.336B 0.00
Ascentage Pharma Group - (AAPG) China $2.306B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.283B 0.00
ImmunityBio (IBRX) United States $2.233B 0.00
Apellis Pharmaceuticals (APLS) United States $2.192B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.180B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.089B 0.00
NovoCure (NVCR) Jersey $2.067B 0.00
Vericel (VCEL) United States $2.060B 1364.00
Bavarian Nordic (BVNRY) Denmark $2.011B 10.62
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.962B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.962B 13.04
Ligand Pharmaceuticals (LGND) United States $1.960B 0.00
Denali Therapeutics (DNLI) United States $1.950B 0.00
Belite Bio (BLTE) United States $1.942B 0.00
CG Oncology (CGON) United States $1.939B 0.00
Kymera Therapeutics (KYMR) United States $1.920B 0.00
Amicus Therapeutics (FOLD) United States $1.915B 207.33
Certara (CERT) United States $1.853B 34.61
Apogee Therapeutics (APGE) United States $1.818B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.806B 0.00
Agios Pharmaceuticals (AGIO) United States $1.726B 0.00
Twist Bioscience (TWST) United States $1.693B 0.00
Beam Therapeutics (BEAM) United States $1.692B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.666B 0.00
IDEAYA Biosciences (IDYA) United States $1.648B 0.00
Disc Medicine (IRON) United States $1.641B 0.00
Biohaven (BHVN) United States $1.597B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.560B 0.00
Edgewise Therapeutics (EWTX) United States $1.495B 0.00
Janux Therapeutics (JANX) United States $1.492B 0.00
GRAIL (GRAL) United States $1.445B 0.00
BGM Group (BGM) China $1.425B 0.00
Structure Therapeutics (GPCR) United States $1.408B 0.00
Travere Therapeutics (TVTX) United States $1.407B 0.00
Mesoblast (MESO) Australia $1.386B 0.00
89BIO (ETNB) United States $1.385B 0.00
Adaptive Biotechnologies (ADPT) United States $1.357B 0.00
Celldex Therapeutics (CLDX) United States $1.351B 0.00
Liquidia Technologies (LQDA) United States $1.312B 0.00
Vera Therapeutics (VERA) United States $1.253B 0.00
MannKind (MNKD) United States $1.252B 25.75
ANI Pharmaceuticals (ANIP) United States $1.252B 12.90
Pacira BioSciences (PCRX) United States $1.192B 11.34
Dynavax Technologies (DVAX) United States $1.177B 70.00
Novavax (NVAX) United States $1.174B 2.74
Anbio Biotechnology (NNNN) Germany $1.108B 0.00
Viridian Therapeutics (VRDN) United States $1.107B 0.00
Mineralys Therapeutics (MLYS) United States $1.040B 0.00
MiMedx (MDXG) United States $0.979B 23.68
Arcus Biosciences (RCUS) United States $0.955B 0.00
NeoGenomics (NEO) United States $0.954B 0.00
Intellia Therapeutics (NTLA) United States $0.949B 0.00
Geron (GERN) United States $0.924B 0.00
CureVac (CVAC) Germany $0.918B 4.45
WAVE Life Sciences (WVE) Singapore $0.917B 0.00
Spyre Therapeutics (SYRE) United States $0.905B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.848B 0.00
CorMedix Inc (CRMD) United States $0.838B 56.18
Pharvaris (PHVS) Netherlands $0.836B 0.00
UniQure (QURE) Netherlands $0.830B 0.00
Oculis Holding AG (OCS) Switzerland $0.830B 0.00
Gyre Therapeutics (GYRE) United States $0.814B 217.00
Zymeworks (ZYME) United States $0.803B 0.00
LENZ Therapeutics (LENZ) United States $0.793B 0.00
Nuvation Bio (NUVB) United States $0.783B 0.00
Niagen Bioscience (NAGE) United States $0.778B 109.78
Praxis Precision Medicines (PRAX) United States $0.765B 0.00
Nurix Therapeutics (NRIX) United States $0.741B 0.00
Immunome (IMNM) United States $0.739B 0.00
Pharming Group (PHAR) Netherlands $0.706B 0.00
ArriVent BioPharma (AVBP) United States $0.698B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.670B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Replimune (REPL) United States $0.643B 0.00
Anavex Life Sciences (AVXL) United States $0.643B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.636B 0.00
Trevi Therapeutics (TRVI) United States $0.628B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Vir Biotechnology (VIR) United States $0.622B 0.00
Immatics (IMTX) Germany $0.621B 0.00
Arbutus Biopharma (ABUS) United States $0.617B 0.00
AnaptysBio (ANAB) United States $0.601B 0.00
Iovance Biotherapeutics (IOVA) United States $0.594B 0.00
Dianthus Therapeutics (DNTH) United States $0.593B 0.00
Keros Therapeutics (KROS) United States $0.592B 0.00
AbCellera Biologics (ABCL) Canada $0.588B 0.00
GH Research (GHRS) Ireland $0.581B 0.00
Sionna Therapeutics (SION) United States $0.561B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.557B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.550B 0.00
Cogent Biosciences (COGT) United States $0.549B 0.00
Eton Pharmaceuticals (ETON) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Stoke Therapeutics (STOK) United States $0.511B 11.85
Bicara Therapeutics (BCAX) United States $0.506B 0.00
Tyra Biosciences (TYRA) United States $0.493B 0.00
Upstream Bio (UPB) United States $0.493B 0.00
Kura Oncology (KURA) United States $0.488B 0.00
REGENXBIO (RGNX) United States $0.487B 0.00
Zenas BioPharma (ZBIO) United States $0.478B 0.00
Arvinas (ARVN) United States $0.475B 0.00
Castle Biosciences (CSTL) United States $0.465B 31.57
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Verastem (VSTM) United States $0.457B 0.00
Oric Pharmaceuticals (ORIC) United States $0.451B 0.00
Maze Therapeutics (MAZE) United States $0.450B 0.00
Sana Biotechnology (SANA) United States $0.449B 0.00
PureTech Health (PRTC) United States $0.437B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.410B 0.00
MeiraGTx Holdings (MGTX) United States $0.410B 0.00
Septerna (SEPN) United States $0.409B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.409B 0.00
Sage Therapeutics (SAGE) United States $0.409B 0.00
MBX Biosciences (MBX) United States $0.406B 0.00
Precigen (PGEN) United States $0.404B 0.00
Tectonic Therapeutic (TECX) United States $0.404B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.402B 0.00
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Celcuity (CELC) United States $0.395B 0.00
Rapport Therapeutics (RAPP) United States $0.395B 0.00
Humacyte (HUMA) United States $0.392B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.391B 0.00
Kamada (KMDA) Israel $0.381B 22.86
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Fortrea Holdings (FTRE) United States $0.367B 10.15
Checkpoint Therapeutics (CKPT) United States $0.365B 0.00
Myriad Genetics (MYGN) United States $0.360B 0.00
Abivax SA (ABVX) France $0.360B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.356B 0.00
Prothena (PRTA) Ireland $0.354B 0.00
Fulcrum Therapeutics (FULC) United States $0.348B 0.00
Emergent Biosolutions (EBS) United States $0.347B 0.00
Erasca (ERAS) United States $0.346B 0.00
Olema Pharmaceuticals (OLMA) United States $0.345B 0.00
Absci (ABSI) United States $0.339B 0.00
Benitec Biopharma (BNTC) United States $0.338B 0.00
ATyr Pharma (ATYR) United States $0.334B 0.00
Rezolute (RZLT) United States $0.333B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.331B 0.00
Abeona Therapeutics (ABEO) United States $0.328B 0.00
ITeos Therapeutics (ITOS) United States $0.328B 0.00
Alpha Teknova (TKNO) United States $0.319B 0.00
Cytek Biosciences (CTKB) United States $0.307B 0.00
Cidara Therapeutics (CDTX) United States $0.305B 0.00
XOMA Royalty (XOMA) United States $0.297B 0.00
Aura Biosciences (AURA) United States $0.296B 0.00
Inventiva S.A (IVA) France $0.296B 0.00
Compass Therapeutics (CMPX) United States $0.289B 0.00
Entrada Therapeutics (TRDA) United States $0.285B 9.26
Prima BioMed (IMMP) Australia $0.283B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.281B 0.00
Gossamer Bio (GOSS) United States $0.273B 0.00
Tvardi Therapeutics (TVRD) United States $0.272B 0.00
Candel Therapeutics (CADL) United States $0.272B 0.00
Ocugen (OCGN) United States $0.272B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Terns Pharmaceuticals (TERN) United States $0.264B 0.00
Palvella Therapeutics (PVLA) United States $0.262B 0.00
Inozyme Pharma (INZY) United States $0.256B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.255B 0.00
Lifecore Biomedical (LFCR) United States $0.249B 0.00
Atea Pharmaceuticals (AVIR) United States $0.248B 0.00
Neurogene (NGNE) United States $0.246B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.244B 49.62
ADC Therapeutics SA (ADCT) Switzerland $0.241B 0.00
Semper Paratus Acquisition (TVGN) United States $0.241B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.239B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.238B 0.00
Cartesian Therapeutics (RNAC) United States $0.238B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
MaxCyte (MXCT) United States $0.233B 0.00
Allogene Therapeutics (ALLO) United States $0.232B 0.00
Annexon (ANNX) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.231B 0.00
DBV Technologies S.A (DBVT) France $0.230B 0.00
Alumis (ALMS) United States $0.230B 0.00
Amarin (AMRN) Ireland $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Aardvark Therapeutics (AARD) United States $0.228B 0.00
Astria Therapeutics (ATXS) United States $0.221B 0.00
Solid Biosciences (SLDB) United States $0.218B 0.00
Adherex Technologies (FENC) United States $0.217B 0.00
Monopar Therapeutics (MNPR) United States $0.217B 0.00
Design Therapeutics (DSGN) United States $0.216B 0.00
EnGene Holdings (ENGN) Canada $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
GENFIT S.A (GNFT) France $0.211B 0.00
Nuvectis Pharma (NVCT) United States $0.205B 0.00
Bright Minds Biosciences (DRUG) United States $0.204B 0.00
Actuate Therapeutics (ACTU) United States $0.203B 0.00
Cardiff Oncology (CRDF) United States $0.202B 0.00
BioStem Technologies (BSEM) $0.200B 8.15
Tango Therapeutics (TNGX) United States $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
Codexis (CDXS) United States $0.199B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.196B 0.00
Urogen Pharma (URGN) United States $0.193B 0.00
CARGO Therapeutics (CRGX) United States $0.189B 0.00
Galena Biopharma (SLS) United States $0.189B 0.00
Inhibrx Biosciences (INBX) United States $0.186B 0.11
Tiziana Life Sciences (TLSA) United Kingdom $0.185B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.183B 0.00
Kodiak Sciences (KOD) United States $0.182B 0.00
CytomX Therapeutics (CTMX) United States $0.180B 4.65
ProQR Therapeutics (PRQR) Netherlands $0.176B 0.00
ScPharmaceuticals (SCPH) United States $0.175B 0.00
DiaMedica Therapeutics (DMAC) United States $0.174B 0.00
AC Immune (ACIU) Switzerland $0.170B 0.00
Prime Medicine (PRME) United States $0.169B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Rapt Therapeutics (RAPT) United States $0.163B 0.00
Voyager Therapeutics (VYGR) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
Puma Biotechnology (PBYI) United States $0.161B 4.20
Alpha Cognition (ACOG) Canada $0.146B 0.00
BioAge Labs (BIOA) United States $0.146B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.139B 0.00
Instil Bio (TIL) United States $0.138B 0.00
Fate Therapeutics (FATE) United States $0.133B 0.00
Greenwich LifeSciences (GLSI) United States $0.131B 0.00
Editas Medicine (EDIT) United States $0.130B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.126B 0.00
Seer (SEER) United States $0.126B 0.00
EXoZymes (EXOZ) United States $0.125B 0.00
InflaRx (IFRX) Germany $0.124B 0.00
Nkarta (NKTX) United States $0.124B 0.00
Alector (ALEC) United States $0.124B 0.00
TuHURA Biosciences (HURA) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.121B 0.00
Ventyx Biosciences (VTYX) United States $0.120B 0.00
Black Diamond Therapeutics (BDTX) United States $0.114B 33.50
Sangamo Therapeutics (SGMO) United States $0.110B 0.00
Neumora Therapeutics (NMRA) United States $0.110B 0.00
Sagimet Biosciences (SGMT) United States $0.106B 0.00
Agenus (AGEN) United States $0.105B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.103B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
Medicus Pharma (MDCX) United States $0.098B 0.00
Kyverna Therapeutics (KYTX) United States $0.098B 0.00
C4 Therapeutics (CCCC) United States $0.098B 0.00
Genelux (GNLX) United States $0.097B 0.00
Caribou Biosciences (CRBU) United States $0.095B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Nautilus Biotechnology (NAUT) United States $0.092B 0.00
Contineum Therapeutics (CTNM) United States $0.092B 0.00
Elicio Therapeutics (ELTX) United States $0.091B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Cabaletta Bio (CABA) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
23andMe Holding (MEHCQ) United States $0.089B 0.00
Immunic (IMUX) United States $0.088B 0.00
Coherus BioSciences (CHRS) United States $0.088B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.086B 0.00
Adagene (ADAG) China $0.086B 0.00
Senti Biosciences (SNTI) United States $0.083B 0.00
Whitehawk Therapeutics (WHWK) United States $0.083B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.082B 0.00
Alto Neuroscience (ANRO) United States $0.082B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
I-Mab (IMAB) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
IO Biotech (IOBT) Denmark $0.080B 0.00
Pliant Therapeutics (PLRX) United States $0.079B 0.00
TScan Therapeutics (TCRX) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.078B 0.00
Genenta Science S.p.A (GNTA) Italy $0.077B 0.00
IGM Biosciences (IGMS) United States $0.075B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.073B 0.00
Inovio Pharmaceuticals (INO) United States $0.072B 0.00
PDS Biotechnology (PDSB) United States $0.072B 0.00
Jasper Therapeutics (JSPR) United States $0.072B 0.00
Elutia (ELUT) United States $0.071B 0.00
Tenaya Therapeutics (TNYA) United States $0.070B 0.00
Zura Bio (ZURA) United States $0.070B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
MediciNova (MNOV) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Adlai Nortye (ANL) Cayman Islands $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Seres Therapeutics (MCRB) United States $0.067B 0.00
Citius Oncology (CTOR) United States $0.065B 0.00
Exicure (XCUR) United States $0.063B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.062B 0.00
Opus Genetics (IRD) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Skye Bioscience (SKYE) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.058B 0.00
Adicet Bio (ACET) United States $0.057B 0.00
TELA Bio (TELA) United States $0.057B 0.00
VTv Therapeutics (VTVT) United States $0.057B 0.00
Repare Therapeutics (RPTX) Canada $0.057B 0.00
Renovaro (RENB) United States $0.056B 0.00
Forte Biosciences (FBRX) United States $0.056B 0.00
Biomea Fusion (BMEA) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
Immuneering (IMRX) United States $0.055B 0.00
Ikena Oncology (IKNA) United States $0.055B 0.00
Celularity (CELU) United States $0.055B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.053B 0.00
Kalaris Therapeutics (KLRS) United States $0.052B 0.00
Shattuck Labs (STTK) United States $0.052B 0.00
Werewolf Therapeutics (HOWL) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Quince Therapeutics (QNCX) United States $0.050B 0.00
Cue Biopharma (CUE) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
PepGen (PEPG) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.046B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
Rein Therapeutics (RNTX) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
RenovoRx (RNXT) United States $0.044B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.043B 0.00
Atara Biotherapeutics (ATRA) United States $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Kronos Bio (KRON) United States $0.042B 0.00
Connect Biopharma Holdings (CNTB) United States $0.042B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Spero Therapeutics (SPRO) United States $0.039B 0.00
Annovis Bio (ANVS) United States $0.039B 0.00
Alterity Therapeutics - (ATHE) Australia $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
Boundless Bio (BOLD) United States $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Aligos Therapeutics (ALGS) United States $0.034B 0.00
Scilex Holding (SCLX) United States $0.032B 0.00
Quantum Biopharma (QNTM) Canada $0.031B 0.00
FibroBiologics (FBLG) United States $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
OnKure Therapeutics (OKUR) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.026B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
CalciMedica (CALC) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Advanced Biomed (ADVB) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Passage Bio (PASG) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Vor Biopharma (VOR) $0.022B 0.00
Clene (CLNN) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Imunon (IMNN) United States $0.020B 0.00
Ovid Therapeutics (OVID) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Lexaria Bioscience (LEXX) Canada $0.019B 0.00
ABVC BioPharma (ABVC) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
HOOKIPA Pharma (HOOK) United States $0.018B 0.00
X4 Pharmaceuticals (XFOR) United States $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Cingulate (CING) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Equillium (EQ) United States $0.015B 0.00
NextCure (NXTC) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.011B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sensei Biotherapeutics (SNSE) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00